Wordt geladen...
Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways
BACKGROUND: Ovarian epithelial tumor (OET) is a silent disease of late diagnosis and poor prognosis. Currently treatment options are limited and patient response to treatment is difficult to predict so there is a serious need to delineate the real pathogenesis to predict tumour prognosis. Prohibitin...
Bewaard in:
| Gepubliceerd in: | J Ovarian Res |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5399399/ https://ncbi.nlm.nih.gov/pubmed/28427435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-017-0325-4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|